MFA Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13
Closed -$1.09K 189
2024
Q3
$1.09K Hold
13
﹤0.01% 454
2024
Q2
$892 Buy
+13
New +$868 ﹤0.01% 480
2022
Q1
Sell
-20,095
Closed -$1.46M 69
2021
Q4
$1.46M Buy
20,095
+167
+0.8% +$11.5K 0.62% 29
2021
Q3
$1.39M Buy
19,928
+434
+2% +$30.5K 0.64% 30
2021
Q2
$1.34M Buy
19,494
+1,479
+8% +$98.8K 0.61% 33
2021
Q1
$1.16M Buy
18,015
+2,558
+17% +$165K 0.56% 34
2020
Q4
$901K Buy
15,457
+643
+4% +$38.8K 0.8% 22
2020
Q3
$936K Buy
14,814
+171
+1% +$11.9K 0.99% 22
2020
Q2
$1.13M Sell
14,643
-549
-4% -$42.1K 0.73% 27
2020
Q1
$1.13M Buy
15,192
+2,600
+21% +$180K 1.1% 28
2019
Q4
$810K Buy
12,592
+611
+5% +$39.8K 0.59% 24
2019
Q3
$759K Buy
11,981
+534
+5% +$34.9K 0.62% 26
2019
Q2
$773K Buy
11,447
+1,775
+18% +$117K 0.58% 26
2019
Q1
$622K Buy
9,672
+6,488
+204% +$431K 0.41% 40
2018
Q4
$202K Buy
+3,184
New +$223K 0.2% 39

Other funds holding GILD

MFA Wealth Advisors's GILD Position: Q4 2024 in Review

MFA Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 13 shares — an estimated $1.09K sold.

MFA Wealth Advisors first reported a position in GILD in Q4 2018 and held it in 15 quarters. The position peaked at $1.46M in Q4 2021. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • MFA Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • MFA Wealth Advisors sold 13 Gilead Sciences shares in Q4 2024, an estimated $1.09K.
  • MFA Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and held it in 15 quarters.
  • MFA Wealth Advisors's Gilead Sciences position peaked at $1.46M in Q4 2021.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on MFA Wealth Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.